Cilnidipine Tablets IP 20 mg – Dual Channel Control for Better Blood Pressure Management
CILONOIA 20: Cilnidipine 20mg is an advanced calcium channel blocker formulated to manage high blood pressure and prevent cardiovascular complications such as angina. It acts on both L-type calcium channels (causing vasodilation) and N-type calcium channels (inhibiting the release of norepinephrine), which together result in effective blood pressure reduction and improved vascular relaxation.
Recommended by Specialists
✅ Cardiologists – For patients with moderate to severe hypertension or cardiovascular risks.
✅ General Physicians – As a step-up therapy in uncontrolled or high-risk hypertensive cases.
✅ Nephrologists – For hypertensive patients with chronic kidney disease, Cilnidipine supports renal protection by reducing proteinuria.
✅ Diabetologists – Particularly effective in hypertensive patients with type 2 diabetes due to its minimal impact on metabolic parameters and kidney safety.
Key Benefits of Cilnidipine Tablets IP 20 mg
✅ Dual Channel Blockade mechanism: Cilnidipine 20 mg uniquely blocks both L-type and N-type calcium channels, offering superior blood pressure control by reducing vascular resistance and sympathetic nerve activity.
✅Reduced Risk of Tachycardia: Unlike conventional calcium channel blockers, Cilnidipine minimizes reflex tachycardia by lowering sympathetic stimulation through N-type channel inhibition.
✅Renal-Friendly Formula: Proven to reduce proteinuria, making it especially beneficial in managing hypertension in diabetic or chronic kidney disease patients.
Indications
✅Moderate to Severe Hypertension
✅Hypertension in Type 2 Diabetes Mellitus (T2DM)
✅Hypertension with Chronic Kidney Disease (CKD)
✅Hypertension with Multiple Cardiovascular Risk Factors